Michele Long
Family · South Charleston, WVNPI 1295077220
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,504 and has fallen 50.9% since, to $738 in 2025. Among family clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$564
- Lundbeck LLC$499
- Otsuka America Pharmaceutical, Inc.$461
- Axsome Therapeutics, Inc.$424
- Takeda Pharmaceuticals U.S.A., Inc.$397
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,505100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 87 | $1,015 |
| Johnson & Johnson(2 entities) | 24 | $564 |
| Lundbeck LLC | 24 | $499 |
| Otsuka America Pharmaceutical, Inc. | 23 | $461 |
| Axsome Therapeutics, Inc. | 18 | $424 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $397 |
| Ironshore Pharmaceuticals Inc. | 14 | $300 |
| Corium, LLC | 14 | $284 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $283 |
| Neos Therapeutics, LP | 12 | $217 |
| Tris Pharma Inc | 10 | $211 |
| Alkermes, Inc. | 9 | $181 |
| Teva Pharmaceuticals USA, Inc. | 8 | $147 |
| Supernus Pharmaceuticals, Inc. | 8 | $131 |
| Jazz Pharmaceuticals Inc. | 6 | $106 |
| Vanda Pharmaceuticals Inc. | 5 | $104 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$5,505 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 14 | $248 |
Paid to pharmacies, not to this prescriber.
Other family in South Charleston
- Sharon LakeSouth Charleston$12K
- Lisa McClureSouth Charleston$10K
- April BowlesSouth Charleston$10K
- Jeremy SmithSouth Charleston$10K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.